Sanofi teams up with Medtronic in diabetes
This article was originally published in Scrip
Executive Summary
Parisian big pharma Sanofi and US medical device giant Medtronic are planning to team up under an "open innovation" alliance to develop diabetes drug-device combinations focused on improving patient adherence to medicines.